The store will not work correctly when cookies are disabled.
(S)-2-isopropyl-5-methylphenyl 5-oxopyrrolidine-2-carboxylate
ID: ALA4251169
PubChem CID: 145986293
Max Phase: Preclinical
Molecular Formula: C15H19NO3
Molecular Weight: 261.32
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(C(C)C)c(OC(=O)[C@@H]2CCC(=O)N2)c1
Standard InChI: InChI=1S/C15H19NO3/c1-9(2)11-5-4-10(3)8-13(11)19-15(18)12-6-7-14(17)16-12/h4-5,8-9,12H,6-7H2,1-3H3,(H,16,17)/t12-/m0/s1
Standard InChI Key: ZEMBRIGAAWVYRR-LBPRGKRZSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
1.6178 -17.6646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4350 -17.6646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6894 -16.8879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0264 -16.4057 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.3677 -16.8879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5904 -16.6357 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.3926 -16.4718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1046 -16.8728 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.3838 -15.6628 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1134 -17.6899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4069 -18.1016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4153 -18.9180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1279 -19.3198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8335 -18.8993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8216 -18.0843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5231 -17.6650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2369 -18.0629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5108 -16.8479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7118 -19.3338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
5 6 2 0
3 7 1 6
7 8 1 0
7 9 2 0
8 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
15 16 1 0
16 17 1 0
16 18 1 0
12 19 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 261.32 | Molecular Weight (Monoisotopic): 261.1365 | AlogP: 2.30 | #Rotatable Bonds: 3 |
Polar Surface Area: 55.40 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.24 | CX Basic pKa: ┄ | CX LogP: 2.67 | CX LogD: 2.67 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.67 | Np Likeness Score: -0.21 |
References
1. Gang FL, Zhu F, Li XT, Wei JL, Wu WJ, Zhang JW.. (2018) Synthesis and bioactivities evaluation of l-pyroglutamic acid analogues from natural product lead., 26 (16): [PMID:30119995] [10.1016/j.bmc.2018.07.041] |